Skip to main content

ESMO 2016: a short overview on melanoma

By 8 Ottobre 2016Aprile 7th, 2021No Comments

Immunotherapy still holds a relevant role in treating melanoma. Paolo Ascierto, Direttore della Struttura Complessa di Oncologia Medica e Terapie Innovative dell’Istituto nazionale Tumori IRCCS Fondazione Pascale, provides a short overview on treatment options, with a focus on the adjuvant setting and on results from 169 phase III trial.